Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinoma

Molecular markers for predicting or monitoring the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC) remain to be identified. We have now measured the serum concentrations of 25 angiogenesis-related molecules with antibody suspension bead array systems for 25 mCRC patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hayashi, Hidetoshi, Arao, Tokuzo, Matsumoto, Kazuko, Kimura, Hideharu, Togashi, Yosuke, Hirashima, Yoshinori, Horita, Yosuke, Iwasa, Satoru, Okita, Natsuko Tsuda, Honma, Yoshitaka, Takashima, Atsuo, Kato, Ken, Hamaguchi, Tetsuya, Shimada, Yasuhiro, Nakagawa, Kazuhiko, Nishio, Kazuto, Yamada, Yasuhide
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2014
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4058029/
https://ncbi.nlm.nih.gov/pubmed/24809949
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados